Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/1498 stock hub

HKG/1498 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/1498is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

171.2M

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/1498

In the news

Latest news · HKG/1498

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROE-29.1

P25 -14.7P50 2P75 9.4

ROIC-3.6

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/1498 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

HKD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	474
Employees Change	-5%
Employees Change Percent	-1.04
Enterprise value	HKD 486.5M
Exchange	Hong Kong Stock Exchange
Financial currency	HKD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KYG7306Y1044
Last refreshed	2026-05-10
Market cap	HKD 171.2M
Price	HKD 0.32
Price currency	HKD
Rev Per Employee	762,161x
Sector	Healthcare
Sic	2834
Symbol	hkg/1498
Website	https://www.purapharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-20.57%
EV Earnings	-13.81x
EV/EBITDA	19.51x
EV/FCF	17.23x
EV/Sales	1.45x
FCF yield	16.49%
P/B ratio	1.31x
P/S ratio	0.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-4.83%
EBITDA Margin	1.85%
FCF margin	8.4%
Gross margin	53.6%
Gross Profit	HKD 180.2M
Gross Profit Growth	-3.66%
Gross Profit Growth Q	-7.45%
Gross Profit Growth3 Y	-7.09%
Gross Profit Growth5 Y	-3.73%
Net Income	HKD -35.2M
Net Income Growth Quarters	1%
Net Income Growth Years	4%
Pretax Margin	-10.24%
Profit Margin	-10.48%
Profit Per Employee	HKD -79,868
ROA	-1.44
Roa5y	-1.92
ROCE	-7.57
ROE	-29.15
Roe5y	-34.13
ROIC	-3.64
Roic5y	-4.71

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-20.35%
Cagr1y	-33.35%
Cagr3y	-33.12%
Cagr5y	-14%
EPS Growth Quarters	1
EPS Growth Years	4
FCF Growth	-68.33%
FCF Growth3 Y	-29.61%
FCF Growth5 Y	1.94%
OCF Growth	-72.57%
OCF Growth10 Y	-13.37%
OCF Growth3 Y	-33.64%
OCF Growth5 Y	-5.7%
Revenue Growth	-12.03x
Revenue Growth Q	-6.1x
Revenue Growth Years	0x
Revenue Growth3 Y	-7.11x
Revenue Growth5 Y	-4.01x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.48
Assets	HKD 693.8M
Cash	HKD 35.9M
Current Assets	HKD 227.1M
Current Liabilities	HKD 479.4M
Debt	HKD 351.1M
Debt EBITDA	HKD 14.03
Debt Equity	HKD 2.69
Debt FCF	HKD 12.43
Equity	HKD 130.5M
Interest Coverage	-0.78
Liabilities	HKD 563.3M
Long Term Assets	HKD 466.7M
Long Term Liabilities	HKD 83.9M
Net Cash	HKD -315.2M
Net Cash By Market Cap	HKD -184
Net Debt EBITDA	HKD 50.62
Net Debt Equity	HKD 2.42
Net Debt FCF	HKD 11.16
Tangible Book Value	HKD 45.5M
Tangible Book Value Per Share	HKD 0.09
WACC	4.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.47
Inventory Turnover	1.4
Net Working Capital	HKD -4.1M
Quick ratio	0.2
Working Capital	HKD -252.3M
Working Capital Turnover	HKD -1.42

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6%
Dividend per share	HKD 0
Last Dividend	HKD 0.02

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-89.72%
1Y total return	-33.33%
200-day SMA	0.38
3Y total return	-70.09%
50-day SMA	0.31
50-day SMA vs 200-day SMA	50under200
5Y total return	-52.94%
All Time High	5.9
All Time High Change	-94.58%
All Time High Date	2015-07-14
All Time Low	0.28
All Time Low Change	16.36%
All Time Low Date	2026-04-01
ATR	0.01
Beta	0.21
Beta1y	0.3
Beta2y	0.05
Ch YTD	-9.86
High	0.32
High52	0.55
High52 Date	2025-05-20
High52ch	-41.82%
Low	0.29
Low52	0.28
Low52 Date	2026-04-01
Low52ch	16.36%
Ma50ch	3.13%
Price vs 200-day SMA	-15.97%
RSI	61.72
RSI Monthly	28.07
RSI Weekly	37.21
Sharpe ratio	-1.07x
Sortino ratio	-1.36
Total Return	-6%
Tr YTD	-9.86
Tr1m	4.92%
Tr1w	6.67%
Tr3m	-3.03%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -16.2M
Operating margin	-4.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	402,695,921%
Net Borrowing	-45,905,000
Shares Insiders	24.74%
Shares Institutions	26.17%
Shares Out	535,053,312
Shares Qo Q	12.01%
Shares Yo Y	6%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 28.2M
Average Volume	440,737.5x
Bv Per Share	0.24
CAPEX	HKD -284,000
Ch10y	-90.59
Ch1m	4.92
Ch1w	6.67
Ch1y	-33.33
Ch3m	-3.03
Ch3y	-70.09
Ch5y	-52.94
Ch6m	-23.81
Change	8.47%
Change From Open	6.67
Close	0.3
Days Gap	1.69
Depreciation Amortization	22,450,000
Dollar Volume	287,680
Earnings Date	2026-05-26
EBIT	HKD -16.2M
EBITDA	HKD 6.2M
EPS	HKD -0.08
F Score	4
FCF	HKD 28.2M
FCF EV Yield	5.81x
FCF Per Share	HKD 0.05
Financing CF	-46,335,000
Fiscal Year End	December
Founded	1,998
Goodwill	17,944,000
Income Tax	HKD 813,000
Investing CF	24,124,000
Is Primary Listing	1
Last Earnings Date	2026-03-25
Last Report Date	2025-12-31
Ma150	0.36
Ma150ch	-10.14%
Ma20	0.3
Ma20ch	7.31%
Net CF	3,376,000
Next Earnings Date	2026-05-26
Open	0.3
P FCF Ratio	6.06
P OCF Ratio	6
Position In Range	100
Ppne	352,721,000
Price Date	2026-05-08
Price EBITDA	HKD 27.49
Ptbv Ratio	3.76
Relative Volume	2.27x
Revenue	336,113,000x
Tax By Revenue	0.24x
Tr6m	-23.81%
Volume	899,000
Z Score	-0.07

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/1498 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/1498 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/1498?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.2%

Share of float held by funds and institutions

Insider ownership

+24.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+6.0%

Negative means the company is buying back shares.

Technical

HKG/1498 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.7

Neutral momentum band

Price vs 200-day MA

-16.0%

50/200-day relationship not available

Beta (5Y)

0.21

Less volatile than the market

Sharpe ratio

-1.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/1498

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/1498 stock rating?

hkg/1498 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/1498 analysis?

The full report lives at /stocks/hkg/1498/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/1498?

The latest report frames hkg/1498 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/1498 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.